Virtual Medicinal Product (VMP)
-
Temsirolimus 30mg/1.2ml solution for infusion vials and diluent
Name Details
Current Name
Temsirolimus 30mg/1.2ml solution for infusion vials and diluent
|
Start Date
15-01-2009
|
End Date
|
Previous Name
Temsirolimus 30mg/1.2ml solution for injection vials and diluent
|
Start Date
30-10-2008
|
End Date
14-01-2009
|
|
Abbreviated Name
Temsirolimus 30mg/1.2ml inf vials and diluent
|
Start Date
15-01-2009
|
|
Temsirolimus 30mg/1.2ml soln for inj vials & diluent |
Previous Start Date
30-10-2008
|
Previous End Date
14-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.2
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01EG01
BNF |
Current BNF
08010500
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010500
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
35915411000001108 |
19-10-2018 |
|
426944004 |
30-10-2008 |
18-10-2018 |
VMP Ingredients
VMP ingredients table
Temsirolimus |
Based on Ingredient Substance |
|
25 mg |
1 ml |
Name
Temsirolimus
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
25.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Temsirolimus
-
VMP
(Current) Temsirolimus 30mg/1.2ml solution for...
Virtual Medicinal Product Pack (VMPP) Information